BARCELONA, Spain--(BUSINESS WIRE)--
Veeva also announces open API making it easier to integrate customer data with third-party applications and services
Open approach gives industry flexibility, choice to leverage their customer data without restrictions
2019 Veeva Commercial & Medical Summit, Europe -- Life sciences companies want the freedom to use their customer reference data in the way that best meets their business needs. To give the industry even greater flexibility and choice in how they use their data, Veeva Systems (VEEV) today announced Veeva OpenData Explorer and Veeva OpenData API.
Veeva OpenData Explorer is a new web-based portal to access approximately 16 million healthcare professionals (HCPs), healthcare organizations (HCOs), and their affiliations spanning 34 countries. The open API simplifies integration of Veeva OpenData with third-party applications and services so companies can leverage their customer data where they need it. With these latest innovations, Veeva is giving customers greater choice in how they use Veeva OpenData and making it even easier to access accurate customer data.
“For decades life sciences companies have been forced to deal with burdensome third-party agreements (TPAs) that restrict how they can use their data,” said Rebecca Silver, general manager of Veeva OpenData. “Our open approach is eliminating the data restrictions that have historically held the industry back. Customers can use Veeva OpenData the way that works best for them and with the software and data products that meet their business needs.”
Veeva OpenData Explorer gives headquarters users the option to access comprehensive customer data through a web-based portal. Customers can login to view their customer data regardless of the master data management (MDM) or CRM system they use. Now business functions such as compliance, sales, and commercial operations can quickly check all active HCP and HCOs in real-time online and have full visibility across all Veeva OpenData regions.
With the new open API, it is easier to integrate customer data in Veeva OpenData with third-party cloud software such as MDM systems, CRM applications, alignment tools, transparency masters, and sample fulfillment systems. Data syncs automatically so teams can access real-time data across all their systems. This open approach gives companies the freedom to use their customer data without the typical data restrictions imposed by the current legacy data provider.
Veeva OpenData delivers accurate data faster for better customer engagement and sales execution. Data stewards keep data such as physician addresses and specialty areas current and continually up-to-date, validating data change requests in hours versus the industry average of 10 or more days. Customers can be confident that they are working with the right customer data in Veeva OpenData or their third-party systems.
In other news today, Veeva announced new innovations that give business users greater flexibility in Veeva CRM, including Salesforce Lightning Business Apps for Veeva CRM and Veeva CRM Dynamic Attributes. Read today’s Veeva CRM press release to learn more.
Veeva OpenData Explorer is planned for global availability in early 2020. Veeva OpenData API is planned for availability in summer 2020.
For more on Veeva OpenData, visit: veeva.com/eu/opendata
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow @veeva_eu on Twitter: twitter.com/veeva_eu
Like Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 800 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com/eu.
This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the company’s filing on Form 10-Q for the period ended July 31, 2019. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.
® 2019 Veeva Systems Inc. All rights reserved. Veeva and the Veeva logo are trademarks of Veeva Systems Inc.
Veeva Systems Inc. owns other registered and unregistered trademarks.